Literature DB >> 15778417

Origin and uses of primum non nocere--above all, do no harm!

Cedric M Smith1.   

Abstract

The so-called Hippocratic injunction to do no harm has been an axiom central to clinical pharmacology and to the education of medical and graduate students. With the recent reexamination of the nature and magnitude of adverse reactions to drugs, the purposes of this research and review were to discover the origin of this unique Latin expression. It has been reported that the author was neither Hippocrates nor Galen. Searches of writings back to the Middle Ages have uncovered the appearance of the axiom as expressed in English, coupled with its unique Latin, in 1860, with attribution to the English physician, Thomas Sydenham. Commonly used in the late 1800s into the early decades of the 1900s, it was nearly exclusively transmitted orally; it rarely appeared in print in the early 20th century. Its applicability and limitations as a guide to the ethical practice of medicine and pharmacological research are discussed. Despite insufficiencies, it remains a potent reminder that every medical and pharmacological decision carries the potential for harm.

Entities:  

Keywords:  Bioethics and Professional Ethics

Mesh:

Year:  2005        PMID: 15778417     DOI: 10.1177/0091270004273680

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  47 in total

1.  Chiropractic leadership in the eradication of sexual abuse.

Authors:  F Stuart Kinsinger; Wendy Sutton
Journal:  J Can Chiropr Assoc       Date:  2012-03

2.  Primum non nocere….

Authors:  James K Min
Journal:  J Nucl Cardiol       Date:  2015-12-24       Impact factor: 5.952

3.  Promoting Ethical Discussions and Decision Making in a Human Service Agency.

Authors:  Linda A LeBlanc; Olivia M Onofrio; Amber L Valentino; Joshua D Sleeper
Journal:  Behav Anal Pract       Date:  2020-07-28

4.  Personalized drug therapy; the genome, the chip and the physician.

Authors:  Lionel D Lewis
Journal:  Br J Clin Pharmacol       Date:  2005-07       Impact factor: 4.335

5.  Presenteeism: are we hurting the patients we are trying to help?

Authors:  Michael Landry; Chad Miller
Journal:  J Gen Intern Med       Date:  2010-11       Impact factor: 5.128

Review 6.  The increasing frequency of mania and bipolar disorder: causes and potential negative impacts.

Authors:  Sean H Yutzy; Chad R Woofter; Christopher C Abbott; Imad M Melhem; Brooke S Parish
Journal:  J Nerv Ment Dis       Date:  2012-05       Impact factor: 2.254

7.  Foetal surgery and using in utero therapies to reduce the degree of disability after birth. Could it be morally defensible or even morally required?

Authors:  Constantinos Kanaris
Journal:  Med Health Care Philos       Date:  2017-03

8.  First do no harm: safety in the epilepsy monitoring unit.

Authors:  Chad Carlson
Journal:  Epilepsy Curr       Date:  2009 Nov-Dec       Impact factor: 7.500

9.  Ethical Issues in the Introduction of New Technologies: From Mis to POEM.

Authors:  Alberto R Ferreres; Marco Patti
Journal:  World J Surg       Date:  2015-07       Impact factor: 3.352

10.  Communicating the new pharmacovigilance landscape.

Authors:  I Ralph Edwards
Journal:  Drug Saf       Date:  2012-12-01       Impact factor: 5.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.